| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Proquest Management LLC last filed a Form 4 in May 2016, as 10% Owner at EGRX.
At the last filing, the largest reported position was 9,360 shares of EGRX. The EGRX filings lean toward selling, a net 17,980 shares.
Proquest Management LLC has 4 Form 4 filings on record from May 2015 to May 2016, all as 10% Owner at Eagle Pharmaceuticals (EGRX), 2015–2016.
The 6 reported transactions were 4 other transactions and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $732K.
The only open-market sale was 17,980 shares of EGRX at an average $40.72 on May 13, 2016, about $732K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 13, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 17,980 | $40.72 | $732,061.60 | -30.4% |